Patient # | Other Autoimmune disorder | Age at study (years) | Sex | Response to anti-epileptic drug (AED) treatment | GAD65Ab Titer (U/ml) |
---|---|---|---|---|---|
1 | T1D, MS-like disorder | 57 | Female | Refractory | 2 × 104 |
2 | Celiac disease | 43 | Female | Refractory | 4 × 105 |
3 | None | 52 | Female | Refractory | 2 × 104 |
4 | Thyroiditis | 36 | Female | Refractory | 1 × 106 |
5 | None | 72 | Female | Refractory | 1 × 102 |
6 | None | 48 | Female | Refractory | 4 × 102 |
7 | None | 84 | Female | Refractory | 1 × 105 |
8 | None | 29 | Female | Refractory | 4 × 102 |
9 | None | 81 | Male | Refractory | 3 × 105 |
10 | Hashimoto’s, Alopecia Areata | unknown | Female | Refractory | 4 × 105 |
11 | None | unknown | Female | Refractory | 9 × 104 |
12 | Graves’ disease | unknown | Female | Refractory | 2 × 104 |
13 | T1D | 66 | NA | Responsive | 2 × 107 |
14 | T1D | 45 | NA | Refractory | 2 × 107 |
15 | T1D | 6 | NA | No medication | 1 × 103 |
16 | T1D | 16 | NA | Responsive | 9 × 103 |
17 | None | 37 | Female | NA | 5 × 103 |
18 | None | 38 | Female | NA | 8 × 105 |
19 | None | 32 | Female | NA | 6 × 105 |
20 | None | 47 | Female | NA | 8 × 105 |
21 | None | 63 | Female | NA | 5 × 102 |
22 | None | 81 | Male | Responsive | 6 × 102 |
23 | None | 54 | Male | Refractory | 6 × 102 |
24 | None | 13 | Female | NA | 1 × 103 |
25 | None | 4 | Female | NA | 3 × 103 |
26 | None | 22 | Female | Refractory | 2 × 103 |
27 | None | 62 | Male | NA | 3 × 103 |
28 | None | 67 | Male | NA | 3 × 103 |
29 | None | 68 | Male | NA | 2 × 103 |
30 | None | 73 | Male | NA | 2 × 104 |
31 | None | 43 | Female | NA | 8 × 104 |
32 | None | 30 | Female | Refractory | 2 × 105 |
33* | T1D | 78 | Female | NA | 2 × 103 |
34* | T1D | 47 | Female | NA | 2 × 103 |
35* | T1D | 53 | Female | Refractory | 6 × 103 |
36* | T1D | 35 | Female | NA | 2 × 104 |
37* | T1D | 22 | Female | Refractory | 3 × 106 |